ConductScience.org, home

Paper5656160

The natural history of diabetic retinopathy.

Burditt AG and 2 others. Q J Med, 1968. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. The natural history of diabetic retinopathy. Papers, record 5656160. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5656160

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The natural history of diabetic retinopathy.
PubMed
Journal
Q J Med
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
129
iCite
Revised in PubMed
2004-11-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burditt AGA G
2Caird FIF I
3Draper GJG J

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic RetinopathyMajor topic
Adolescent
Adult
Age Factors
Aged
Child
Child, Preschool
Diabetes Mellitus
Female
Glycosuria
Humans
Infant
Infant, Newborn
Middle Aged
Prognosis
Retinal Vessels
Time Factors
Veins

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
37998065Evaluation of Quality of Life and Emotional Disturbances in Patients with Diabetic Retinopathy.Eur J Investig Health Psychol Educ2023https://conductscience.org/library/papers/37998065PubMed
36815723Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/36815723PubMed
35873941Diabetic Retinopathy: An Overview of Treatments.Indian J Endocrinol Metab2022https://conductscience.org/library/papers/35873941PubMed
29576875Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.J Ophthalmol2018https://conductscience.org/library/papers/29576875PubMed
27455994Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.J Biomol Screen2016https://conductscience.org/library/papers/27455994PubMed
24563789Pathophysiology of diabetic retinopathy.ISRN Ophthalmol2013https://conductscience.org/library/papers/24563789PubMed
24324855Anti-vascular endothelial growth factor therapy for diabetic macular edema.Ther Adv Endocrinol Metab2013https://conductscience.org/library/papers/24324855PubMed
8981711Early photocoagulation in patients with either type I or type II diabetes.Trans Am Ophthalmol Soc1996https://conductscience.org/library/papers/8981711PubMed
7304076Diabetes mellitus for 58 years without development of retinopathy.Acta Diabetol Lat1981https://conductscience.org/library/papers/7304076PubMed
7018559Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case report.Br J Ophthalmol1981https://conductscience.org/library/papers/7018559PubMed
6989468[Hyperglycemia and the complications of maturity-onset diabetes].Can Med Assoc J1980https://conductscience.org/library/papers/6989468PubMed
6988279Diet and diabetes.Diabetologia1980https://conductscience.org/library/papers/6988279PubMed
6911006[A new classification scheme of non-proliferative diabetic retinopathy (author's transl)].Albrecht Von Graefes Arch Klin Exp Ophthalmol1981https://conductscience.org/library/papers/6911006PubMed
6812752Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6812752PubMed
6639910Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men.Br J Ophthalmol1983https://conductscience.org/library/papers/6639910PubMed
6590402HLA antigens and risk factors for nephropathy in type 1 (insulin-dependent) diabetes mellitus.Diabetologia1984https://conductscience.org/library/papers/6590402PubMed
6386582Retinopathy is associated with higher glycaemia in maturity-onset type diabetes.Diabetologia1984https://conductscience.org/library/papers/6386582PubMed
6362204Hypoglycemia: a pitfall of insulin therapy.West J Med1983https://conductscience.org/library/papers/6362204PubMed
5472754Pituitary ablation for diabetic retinopathy.Br Med J1970https://conductscience.org/library/papers/5472754PubMed
5075932The prevalence of blindness in diabetics.J R Coll Physicians Lond1972https://conductscience.org/library/papers/5075932PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5656160

GET https://conductscience.org/api/papers/v1/5656160/cited_by?page=2